Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01837251 |
|---|---|
| Brief Title: | Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer |
| First Submitted : | April 16, 2013 |
| First Submitted that Met QC Criteria : | April 22, 2013 |
| First Posted : | April 23, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 8, 2021 |
| Last Update Posted : | July 13, 2021 |